Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems

Disulfiram (DSF) is a thiocarbamate based drug that has been approved for treating alcoholism for over 60 years. Preclinical studies have shown that DSF has anticancer efficacy, and its supplementation with copper (CuII) significantly potentiates the efficacy of DSF. However, the results of clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Xuejia, Jadhav, Sanika, Annaji, Manjusha, Huang, Chung-Hui, Amin, Rajesh, Shen, Jianzhong, Ashby, Charles R., Tiwari, Amit K., Babu, R. Jayachandra, Chen, Pengyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302862/
https://www.ncbi.nlm.nih.gov/pubmed/37376016
http://dx.doi.org/10.3390/pharmaceutics15061567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302862/
https://www.ncbi.nlm.nih.gov/pubmed/37376016
http://dx.doi.org/10.3390/pharmaceutics15061567

Ejemplares similares